T. Rowe Price Associates
LFST icon

T. Rowe Price Associates’s Lifestance Health LFST Stock Holding History

T. Rowe Price Associates’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$954K Buy
149,649
+32,636
+28% +$227K ﹤0.01% 2184
2025
Q4 		$824K Buy
117,013
+35,563
+44% +$215K ﹤0.01% 2161
2025
Q3 		$448K Buy
81,450
+2,994
+4% +$14.7K ﹤0.01% 2410
2025
Q2 		$406K Buy
78,456
+5,677
+8% +$34K ﹤0.01% 2400
2025
Q1 		$485K Buy
72,779
+5,924
+9% +$45K ﹤0.01% 2256
2024
Q4 		$493K Buy
66,855
+9,009
+16% +$64.7K ﹤0.01% 2291
2024
Q3 		$405K Buy
57,846
+8,015
+16% +$48.2K ﹤0.01% 2342
2024
Q2 		$245K Buy
49,831
+7,465
+18% +$45K ﹤0.01% 2508
2024
Q1 		$262K Buy
42,366
+4,681
+12% +$31.5K ﹤0.01% 2498
2023
Q4 		$296K Buy
37,685
+1,933
+5% +$12.5K ﹤0.01% 2381
2023
Q3 		$246K Buy
35,752
+2,455
+7% +$19.9K ﹤0.01% 2422
2023
Q2 		$305K Buy
33,297
+19,674
+144% +$163K ﹤0.01% 2358
2023
Q1 		$102K Buy
13,623
+1,294
+10% +$7.17K ﹤0.01% 2685
2022
Q4 		$61K Buy
12,329
+1,127
+10% +$6.97K ﹤0.01% 2789
2022
Q3 		$75K Buy
+11,202
New +$78.2K ﹤0.01% 2782
2021
Q3 		– Sell
-14,094
Closed -$393K – 2970
2021
Q2 		$393K Buy
+14,094
New +$372K ﹤0.01% 2487

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SPIG
Silversmith Partners I GP Boston, Massachusetts $39.2M AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

T. Rowe Price Associates's LFST Position: Q1 2026 in Review

T. Rowe Price Associates increased its Lifestance Health (LFST) stake by 28% in Q1 2026, buying an estimated $227K and bringing the position to 149,649 shares worth $954K. The position accounts for ﹤0.01% of the portfolio, ranked #2184.

T. Rowe Price Associates first reported a position in LFST in Q2 2021 and has held it in 16 quarters since. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • T. Rowe Price Associates held 149,649 shares of Lifestance Health worth $954K as of Q1 2026.
  • T. Rowe Price Associates bought 32,636 Lifestance Health shares in Q1 2026, an estimated $227K.
  • Lifestance Health made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2184 holding.
  • T. Rowe Price Associates first reported a position in Lifestance Health in Q2 2021 and has held it in 16 quarters since.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.